Antengene Announces Poster Presentation of ATG-022 (Claudin 18.2 ADC) at ESMO 2025 Share Resize Reprints ...

Antengene Corporation Limited ("Antengene", SEHK: 6996.HK), a leading innovative, commercial-stage global biopharmaceutical company dedicated to discovering, developing and commercialising first ...

Antengene Corporation Limited ("Antengene", SEHK: 6996.HK), a leading innovative, commercial-stage global biopharmaceutical company dedicated to discovering, developing and commercialising ...

Antengene Announces Poster Presentation of ATG-022 (Claudin 18.2 ADC) at ESMO 2025 Provided by PR Newswire Jul 27, 2025, 7:31:00 PM ...

SHANGHAI and HONG KONG, July 28, 2025 /PRNewswire/ -- Antengene Corporation Limited ('Antengene', SEHK: 6996.HK), a leading innovative, commercial-stage global biopharmaceutical company dedicated to ...

Aktien » Nachrichten » TELO GENOMICS AKTIE » Telo Genomics Corp.: International Myeloma Society Accepts Telo Genomics' MRD Abstract for Presentation at Its 2025 Meeting Push Mitteilungen ...

The New 'Wicked: For Good' Poster Is Here, and It Reveals More Than Meets the Eye originally appeared on Parade. A new poster teasing the second installment of Wicked has just dropped, and it's ...

- Poster presentation of updated data on BT-001 from the Phase 1 part of the ongoing Phase 1/2a study in solid tumors - LUND, SE / ACCESS Newswire / July 28, 2025 / BioInvent International AB ...

Oral Poster Presentation: ABI-5366, a novel, oral, long-acting herpes simplex virus helicase-primase inhibitor: interim safety and pharmacokinetic results from a phase 1a study in healthy ...